C Jamieson
-
- Antibiotic Use and Resistance 13
- Emergency Medicine top 2%
- Epidemiology top 5%
- Pneumonia and Respiratory Infections 5
- Molecular Medicine top 5%
- Antibiotic Resistance in Bacteria 3
-
- Antibiotics Pharmacokinetics and Efficacy 16
-
- Pharmaceutical studies and practices 5
-
- Pharmaceutical Practices and Patient Outcomes 4
-
- Primary Care and Health Outcomes 3
-
- Pharmaceutical and Antibiotic Environmental Impacts 3
- Co-authors
- J T MacfarlaneHolly RobertsMark WoodheadSimon BaudouinMark L LevyRobert C. GeorgeWei Shen LimManzoor A. Wani
- Cited by
- Applied Microbiology and BiotechnologyCritical Care and Intensive Care MedicineEmergency Medicine
- Journals
- Antimicrobial Agents and Chemotherapy (2 papers)Journal of Antimicrobial Chemotherapy (2 papers)Veterinary Record (1 paper)
- Partner nations
- United KingdomAustraliaFrance
In The Last Decade
C Jamieson
34 papers receiving 1.4k citations
Hit Papers
Peers
Comparison fields: 5 of 118
- Applied Microbiology and Biotechnology 140
- Critical Care and Intensive Care Medicine 286
- Emergency Medicine 306
- Epidemiology 959
- Molecular Medicine 115
Countries citing papers authored by C Jamieson
This map shows the geographic impact of C Jamieson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C Jamieson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C Jamieson more than expected).
Fields of papers citing papers by C Jamieson
This network shows the impact of papers produced by C Jamieson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C Jamieson. The network helps show where C Jamieson may publish in the future.
Co-authorship network
The 25 scholars most cited alongside C Jamieson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 3 | |
| 4 | 2024 | 0 | |
| 5 | 2024 | 0 | |
| 6 | 2024 | 1 | |
| 7 | 2023 | 2 | |
| 8 | 2023 | 1 | |
| 9 | 2023 | 1 | |
| 10 | 2023 | 6 | |
| 11 | 2022 | 5 | |
| 12 | 2021 | 13 | |
| 13 | 2021 | 12 | |
| 14 | 2020 | 15 | |
| 15 | 2016 | 63 | |
| 16 | 2013 | 1 | |
| 17 | 2010 | 34 | |
| 18 | BTS guidelines for the management of community acquired pneumonia in adults: update 2009breakdown → | 2009 | 999 |
| 19 | 2007 | 3 | |
| 20 | 2003 | 18 |
About C Jamieson
C Jamieson is a scholar working on Applied Microbiology and Biotechnology, Geriatrics and Gerontology, Pharmacology, Molecular Medicine and Occupational Therapy, having authored 38 papers that have together received 1.5k indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (16 papers), Antibiotic Use and Resistance (13 papers), Pneumonia and Respiratory Infections (5 papers), Pharmaceutical studies and practices (5 papers), Pharmaceutical Practices and Patient Outcomes (4 papers), Antibiotic Resistance in Bacteria (3 papers), Primary Care and Health Outcomes (3 papers) and Pharmaceutical and Antibiotic Environmental Impacts (3 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (140 citations), Critical Care and Intensive Care Medicine (286 citations), Emergency Medicine (306 citations), Epidemiology (959 citations) and Molecular Medicine (115 citations). C Jamieson has collaborated with scholars based in United Kingdom, Australia and France. Frequent co-authors include J T Macfarlane, Holly Roberts, Mark Woodhead, Simon Baudouin, Mark L Levy, Robert C. George, Wei Shen Lim, Manzoor A. Wani, Robert C. Read and Adam T. Hill. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, Journal of Antimicrobial Chemotherapy, Veterinary Record, Atherosclerosis and Thorax.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.